ATRX Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ATRX monoclonal antibodies for various research applications. ATRX monoclonal antibodies enable techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATRX, or Alpha Thalassemia/Mental Retardation Syndrome X-Linked, is a chromatin remodeling protein that plays a crucial role in gene expression regulation and maintaining genomic stability. ATRX dysfunction is associated with various diseases, including certain types of cancer and developmental disorders, making it a significant focus in understanding these conditions. ATRX research has revealed important mechanisms in DNA replication, telomere maintenance, and chromatin organization. Understanding ATRX function has opened new avenues for investigating cancer biology and genetic disorders. Ongoing studies of ATRX continue to uncover its role in cell cycle regulation and DNA damage response. ATRX monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge of chromatin biology and disease mechanisms.